References
- . Brumfitt, W., Percival, A. & Carter, M. J.: Treatment of urinary tract infection with ampicillin. Lancet 1: 131, 1962.
- . Brumfitt, W. & Percival, A.: Laboratory control of antibiotic therapy in urinary tract infection. Ann NY Acad Sci 145: 329, 1967.
- . von Daehne, W., Frederiksen, E., Gundersen, E., Lund, P., Mørch, P., Petersen, H. J., Roholt, K., Tybring, L. & Godtfredsen, W. O.: Acyloxymethyl esters of ampicillin. J Med Chem 13: 607, 1970.
- . Foltz, E. L., West, J. W., Breslow, I. H. & Wallick, H.: Clinical pharmacology of pivampicillin. Antimicrob Agents Chemother, p. 442, 1970.
- . Frederiksen, E., Godtfredsen, W. O., Nielsen, B. & Roholt, K.: Pivampicillinklorid: et nyt bredspektret antibiotikum til oral anvendelse. Nord Med 86: 1376, 1971.
- . Jordan, M. C., de Maine, J. B. & Kirby, W. M. M.: Clinical pharmacology of pivampicillin as compared with ampicillin. Antimicrob Agents Chemother, p. 438, 1970.
- . Kirby, W. M. M. & Kind, A. C.: Clinical pharmacology of ampicillin and hetacillin. Ann NY Acad Sci 145: 291, 1967.
- . Knudsen, E. T., Rolinson, G. N. & Stevens, S.: Absorption and excretion of “Penbritin”. Br Med J 2: 198, 1961.
- . Nilsson, L. B.: Långtidsbehandling med pivampicillinklorid. Nord Med 86: 1381, 1971.
- . Percival, A., Brumfitt, W. & de Louvois, J.: Serum-antibody levels as an indication of clinically apparent pyelonephritis. Lancet 2: 1027, 1964.
- . Reeves, D. S. & Brumfitt, W.: Localization of urinary tract infection. In: Urinary tract infection, p. 53 (ed. F. O'Grady & W. Brumfitt). Oxford University Press, London 1968.
- . Winberg, J., Andersen, H. J., Hanson, L. Å. & Lincoln, K.: Studies of urinary tract infection in infancy and childhood. Br Med J 2: 524, 1963.